title: Strongyloides hyperinfection syndrome after intestinal transplantation.
abstract: Strongyloides stercoralis is a helminth with the ability to autoinfect the human host and persist asymptomatically for several years. Immunosuppression can accelerate autoinfection and result in Strongyloides hyperinfection syndrome (SHS), which is associated with significant morbidity and mortality. Immunosuppressed solid organ transplant recipients, particularly in the setting of rejection, are at increased risk for reactivation of latent infections, such as Strongyloides. We describe a case of SHS in an intestinal transplant recipient; we hypothesize that she acquired the infection from the donor. We also review the current literature and address both prophylaxis and treatment of strongyloidiasis in the solid organ transplant patient.
authors.affiliation: Division of Infectious Diseases, Mount Sinai School of Medicine, New York, New York 10029, USA.
authors.forename: G
authors.initials: G
authors.lastname: Patel
authors.forename: A
authors.initials: A
authors.lastname: Arvelakis
authors.forename: B V
authors.initials: BV
authors.lastname: Sauter
authors.forename: G E
authors.initials: GE
authors.lastname: Gondolesi
authors.forename: D
authors.initials: D
authors.lastname: Caplivski
authors.forename: S
authors.initials: S
authors.lastname: Huprikar
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007422:Intestines / Q000637:transplantation*; D008875:Middle Aged; D011183:Postoperative Complications; D017171:Strongyloides stercoralis / Q000472:pathogenicity*; D013322:Strongyloidiasis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D013577:Syndrome; D016896:Treatment Outcome
chemical_list: D000871:Anthelmintics